I gather from presentation, their demographic is targetting 3-8 yo, before the average age of attention treated, fda approved drug medication at 6 yo minimum.
https://www.fda.gov/consumers/consumer-updates/dealing-adhd-what-you-need-know
so having fda approved non drug treatment for the demographic 3-8 is their global market
4 types of attention training
3 potential revenue streams. detect . train . maintenance
tick of approval.
25c major congestion zone then 50c on the charts.
gap fill at 1.50 is backed by FA.
Ann: US CPT Code Reimbursement for TALi Detect, page-430
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
